Clinical Trials · NCT01204840
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Ottawa Fertility Centre
- Enrollment
- 38
- Start date
- Sep 2010
- Locations
- 1 site, Canada
- Primary endpoint
- number of mature oocytes retrieved